Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.80
2.34%
After-hours: Aug 15, 2025, 07:37 PM EDT
Atossa Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 57.86M | 65.12M | 71.08M | 74.77M | 79.53M | 84.07M | 88.57M | 94.03M | 99.39M | 103.87M | 110.89M | 117.37M | 125.54M | 131.49M | 136.38M | 140.04M | 142.43M | 137.57M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 4.7M | 4.7M | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2M | 2M | 1.99M | 2.37M | 2.43M | 2.32M | 2.32M | 2.34M | 642K | 631K | 634K | 629K | 627K | 630K | 1K | 13.41K | 13.41K | 16.47K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | -1.43M | 28K | 737K | 738K | 743K | 610K | 900K | 668K | 1.07M | 934.67K | 817.11K | 720.03K |
Inventory | n/a | n/a | n/a | n/a | 1.09M | 1.37M | 1.49M | n/a | 5.87M | 5.41M | 4.14M | 5.22M | 5.41M | 3.98M | 2.6M | 1.99M | 2.5M | 2.66M |
Other Current Assets | 4.66M | 378K | 229K | 258K | 518K | 508K | 110K | 117K | 117K | 968K | 1.32M | 311K | 1.68M | 820K | 1.3M | 128.06K | 188.88K | 187.24K |
Total Current Assets | 62.52M | 68.74M | 74.46M | 77.11M | 81.72M | 87.06M | 92.22M | 97.65M | 106M | 110.87M | 118.2M | 123.39M | 133.42M | 136.85M | 141.24M | 142.99M | 145.83M | 141.03M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | 23.36K | 19.22K | 23.85K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.46K | 8.92K |
Total Long-Term Assets | 2M | 2M | 1.99M | 2.37M | 4.14M | 4.03M | 4.03M | 4.05M | 2.35M | 5.33M | 5.33M | 3.33M | 627K | 630K | 22K | 36.76K | 37.09K | 49.23K |
Total Assets | 64.52M | 70.75M | 76.44M | 79.48M | 85.86M | 91.09M | 96.25M | 101.69M | 108.36M | 116.2M | 123.53M | 126.72M | 134.05M | 137.48M | 141.26M | 143.02M | 145.87M | 141.08M |
Account Payables | 2.01M | 1.17M | 679K | 1.56M | 1.06M | 1.23M | 806K | 718K | 1.17M | 1.44M | 2.96M | 1.65M | 2.05M | 1.6M | 1.72M | 667.99K | 537.91K | 722.28K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 988.37K | 1.23M | 641.16K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.22K | 4.72K | n/a |
Other Current Liabilities | 3.76M | 2.11M | 3.04M | 2.42M | 1.79M | 3.44M | 1.8M | 1.28M | 849K | 678K | 1.08M | 144K | 865K | 133K | 225K | 92.73K | 548.16K | 7.7K |
Total Current Liabilities | 6.82M | 5.42M | 4.97M | 5.8M | 5.7M | 5.33M | 5.24M | 3.44M | 3.48M | 2.94M | 5.57M | 2.87M | 3.79M | 2.32M | 3.13M | 1.68M | 1.8M | 1.38M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | -1K | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.44M | 2.96M | 1.65M | 2.05M | 1.6M | 1.72M | 669.21K | 542.63K | 730.29K |
Total Liabilities | 6.82M | 5.42M | 4.97M | 5.8M | 5.7M | 5.33M | 5.24M | 3.44M | 3.48M | 2.94M | 5.57M | 2.87M | 3.79M | 2.32M | 3.13M | 1.68M | 1.8M | 1.38M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.22K | 4.72K | 8.01K |
Common Stock | 23.49M | 23.49M | 23.49M | 22.88M | 22.87M | 22.83M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 22.67M | 21.75M |
Retained Earnings | -226.93M | -218.51M | -211.79M | -205.44M | -198.22M | -192.17M | -186.29M | -178.53M | -172.31M | -162.47M | -156.19M | -148.7M | -140.69M | -134.02M | -129.23M | -124.4M | -119.2M | -112.17M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -582K | n/a | -582K | -54K | n/a | -582K | -582K | -0.00 | n/a | n/a |
Shareholders Equity | 57.7M | 65.32M | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M | 98.25M | 104.88M | 113.26M | 117.96M | 123.86M | 130.26M | 135.16M | 138.14M | 141.35M | 144.07M | 139.7M |
Total Investments | n/a | n/a | n/a | n/a | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 4.7M | 4.7M | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a |